Asia Pacific dPCR and qPCR Market Forecast to 2030

Asia Pacific dPCR and qPCR Market Forecast to 2030

Asia Pacific dPCR and qPCR Market Forecast to 2030 – Regional Analysis – By Treatment [Quantitative PCR (qPCR) and Digital PCR (dPCR)], Product (Reagents & Consumables, Instruments, and Software & Services), Application (Research Application, Clinical Application, and Forensic Application), and End User (Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Research Laboratories and Academic Institutes, Forensic Laboratories, and Clinical Research Organizations)

Send Enquiry
Item ID: BMIRE00029880 Category: Tag:

$2,840 – $4,440

Description

The Asia Pacific dPCR and qPCR market was valued at US$ 1,913.43 million in 2022 and is expected to reach US$ 4,139.50 million by 2030; it is estimated to grow at a CAGR of 10.1% from 2022 to 2030.

Technological Advancements in PCR Technologies Drive Asia Pacific dPCR and qPCR Market

Polymerase chain reaction (PCR) is a nearly ubiquitous, robust, and reliable technology used in most molecular biology labs to amplify specific stretches of DNA for genotyping, cloning, and analysis of single nucleotide variations and even serves as the basis for most next-generation sequencing (NGS) preparation. Technological advances are yielding different types of PCR techniques. The use of PCR technology has now been explored into several non-conventional applications, making molecular diagnosis easier and faster. In particular, advances in digital and real-time PCR are used to diagnose diseases, identify viruses and bacteria, and aid forensic investigations. Moreover, the researchers are trying to reduce test time using some nanomaterials. In March 2023, the Center for Augmented Safety System with Intelligence, Sensing of the Korea Institute of Science and Technology (KIST, President: Seok Jin Yoon) announced the development of an ultrafast PCR technology by Dr. Sang Kyung Kim (Director) and Dr. Seungwon Jung’s research team. The ultrafast PCR reduces the test duration by ten times compared to the previous test by utilizing photothermal nanomaterials. The diagnostic performance of the new method is comparable to the current test method, and it can be finished in 5 minutes. Thus, technological advancements in PCR technologies propel the Asia Pacific dPCR and qPCR market growth.

Asia Pacific dPCR and qPCR Market Overview

The Asia Pacific dPCR and qPCR market in Asia Pacific is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. China, India and Japan are three major contributors to the growth of the market which is driven by increasing foreign direct investments in these countries, highly skilled, efficient and large number of labor, and streamlining government policies resulting in high investments for biotechnology sector. In addition, increasing cases of infectious and chronic diseases and government and non-government initiatives are also responsible for fueling the growth of the Asia Pacific dPCR and qPCR market.

Asia Pacific dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific dPCR and qPCR Market Segmentation

The Asia Pacific dPCR and qPCR market is segmented based on treatment, product, application, end user, and country.

Based on treatment, the Asia Pacific dPCR and qPCR market is bifurcated into quantitative PCR (qPCR) and digital PCR (dPCR). The digital PCR (dPCR) segment held a larger share in 2022.

By product, the Asia Pacific dPCR and qPCR market is segmented into reagents & consumables, instruments, and software & services. The reagents & consumables segment held the largest share in 2022.

By application, the Asia Pacific dPCR and qPCR market is research application, clinical application, and forensic application. The clinical application segment held the largest share in 2022. The clinical application segment is further subsegmented into oncology testing, blood screening, infectious disease testing, and other applications.

By end user, the Asia Pacific dPCR and qPCR market is segmented into hospitals and diagnostic centers, pharmaceutical and biotechnology companies, research laboratories and academic institutes, forensic laboratories, and clinical research organizations. The hospitals and diagnostic centers segment held the largest share in 2022.

Based on country, the Asia Pacific dPCR and qPCR market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific dPCR and qPCR market in 2022.

Abbott Laboratories, Thermo Fisher Scientific Inc, Takara Bio Inc, Genome Diagnostics Pvt Ltd, Qiagen NV, Standard BioTools Inc, Lepu Medical Technology Beijing Co Ltd, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, and Agilent Technologies Inc are some of the leading companies operating in the Asia Pacific dPCR and qPCR market.

Summary Info

Industry:

Pricing options:

, ,

Geographical coverage:

, ,

Year of Publication:

At 10.1% CAGR, the Asia Pacific dPCR and qPCR Market is Speculated to be Worth US$ 4,139.50 Million by 2030, Says the Research Team

According to the Research Team’ research, the Asia Pacific dPCR and qPCR market was valued at US$ 1,913.43 million in 2022 and is expected to reach US$ 4,139.50 million by 2030, registering a CAGR of 10.1% from 2022 to 2030. Increasing incidence of genetic and technological advancements in PCR technologies are among the critical factors attributed to the Asia Pacific dPCR and qPCR market expansion.

According to the National Organization’s information on genetic conditions or congenital disabilities, though individual genetic disorders are rare, collectively, they comprise over 15,500 people diagnosed with genetic disorders. Furthermore, the disease is most prevalent in emerging nations such as India. Among India’s tribal communities, ~18 million people are affected by sickle cell trait (SCT), and 1.4 million people are suffering from sickle cell disease (SCD). The adoption of digital PCR is improving as pathologists are trying to track the use of this technology to target various specific DNA sequences and diagnose and design various clinical tests. Digital PCR can target specific DNA sequences in just one molecule of DNA. This new tool allows researchers to isolate rare genetic mutations that are too difficult to segregate with real-time PCR. The COVID-19 outbreak had a significant effect on the polymerase chain reaction market growth. The growing demand in the clinical diagnostic market has a favorable effect on the PCR industry. Nearly all diagnostic tests use RT-PCR to test the people having symptoms of COVID-19 and were urged by healthcare experts to undergo a diagnostic test, while the authorities have not endorsed viral culture tests. The majority of biotech and pharmaceutical businesses were concentrating their efforts on research and development divisions to find novel compounds or therapy approaches for COVID-19. In February 2022, Roche added the Cobas 5800 System, a newly released molecular laboratory instrument, to its COVID-19 PCR portfolio for use in nations that accept the CE certification. These products include the cobas SARS-CoV-2 and influenza A/B tests, as well as the cobas SARS-CoV-2 qualitative test. By offering uniform performance and efficiency across low-, medium–, and high-volume molecular laboratory testing needs, these products broaden the Roche Diagnostics molecular portfolio offering. Additionally, healthcare organizations with limited space or resources can have comprehensive access owing to the new, compact Cobas 5800 System. Better testing accessibility will result from this in nations or settings where larger equipment cannot be accommodated due to a lack of resources or space. Thus, increasing incidence of genetic and infectious diseases in which dPCR and qPCR techniques can be used for diagnosis and treatments support the growth of the Asia Pacific dPCR and qPCR market.

On the contrary, high costs of PCR systems hampers the growth of Asia Pacific dPCR and qPCR market.

Based on treatment, the Asia Pacific dPCR and qPCR market is bifurcated into quantitative PCR (qPCR) and digital PCR (dPCR). The digital PCR (dPCR) segment held 71.3% share of the Asia Pacific dPCR and qPCR market in 2022, amassing US$ 1,364.51 million. It is projected to garner US$ 3,089.15 million by 2030 to expand at 10.8% CAGR during 2022-2030.

By product, the Asia Pacific dPCR and qPCR market is segmented into reagents & consumables, instruments, and software & services. The reagents & consumables segment held 63.4% share of the Asia Pacific dPCR and qPCR market in 2022, amassing US$ 1,213.30 million. It is projected to garner US$ 2,780.77 million by 2030 to expand at 10.9% CAGR during 2022-2030.

By application, the Asia Pacific dPCR and qPCR market is segmented into research application, clinical application, and forensic application. The clinical application segment held 56.0% share of the Asia Pacific dPCR and qPCR market in 2022, amassing US$ 1,072.40 million. It is projected to garner US$ 2,573.61 million by 2030 to expand at 11.6% CAGR during 2022-2030. The clinical application segment is further subsegmented into oncology testing, blood screening, infectious disease testing, and other applications.

By end user, the Asia Pacific dPCR and qPCR market is segmented into hospitals and diagnostic centers, pharmaceutical and biotechnology companies, research laboratories and academic institutes, forensic laboratories, and clinical research organizations. The hospitals and diagnostic centers segment held 56.0% share of the Asia Pacific dPCR and qPCR market in 2022, amassing US$ 1,072.40 million. It is projected to garner US$ 2,573.61 million by 2030 to expand at 11.6% CAGR during 2022-2030.

Based on country, the Asia Pacific dPCR and qPCR market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China held 24.9% share of Asia Pacific dPCR and qPCR market in 2022, amassing US$ 477.21 million. It is projected to garner US$ 1,135.54 million by 2030 to expand at 11.4% CAGR during 2022-2030.

Key players operating in the Asia Pacific dPCR and qPCR market are Abbott Laboratories, Genome Diagnostics Pvt Ltd, Thermo Fisher Scientific Inc, Takara Bio Inc, Qiagen NV, Standard BioTools Inc, Lepu Medical Technology Beijing Co Ltd, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, and Agilent Technologies Inc, among others.

o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific dPCR and qPCR market.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in Asia Pacific dPCR and qPCR market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the dPCR and qPCR market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution

TABLE OF CONTENTS

1. Introduction
1.1 the Research Team Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific dPCR and qPCR Market – Key Industry Dynamics
4.1 Market Drivers
4.1.1 Increasing Incidence of Genetic and Infectious Diseases
4.1.2 Rising Investments and Funds for Gene Synthesis
4.1.3 Technological Advancements in PCR Technologies
4.2 Market Restraints
4.2.1 High Costs of PCR Systems
4.2.2 Technical Limitations Associated with qPCR
4.3 Market Opportunities
4.3.1 Growing Adoption of PCR Methods in Emerging Countries
4.4 Future Trends
4.4.1 Development of Droplet Digital PCR
4.5 Impact Analysis:
5. dPCR and qPCR Market – Asia Pacific Market Analysis
5.1 Asia Pacific dPCR and qPCR Market Revenue (US$ Mn), 2022 – 2030
6. Asia Pacific dPCR and qPCR Market – Revenue and Forecast to 2030 – by Treatment
6.1 Overview
6.2 Asia Pacific dPCR and qPCR Market Revenue Share, by Treatment, 2022 & 2030 (%)
6.3 Quantitative PCR
6.3.1 Overview
6.3.2 Quantitative PCR: Asia Pacific dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
6.4 Digital PCR
6.4.1 Overview
6.4.2 Digital PCR: Asia Pacific dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
7. Asia Pacific dPCR and qPCR Market – Revenue and Forecast to 2030 – by Product
7.1 Overview
7.2 Asia Pacific dPCR and qPCR Market Revenue Share, by Product, 2022 & 2030 (%)
7.3 Reagents & Consumables
7.3.1 Overview
7.3.2 Reagents & Consumables: Asia Pacific dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Instruments
7.4.1 Overview
7.4.2 Instruments: Asia Pacific dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Software & Services
7.5.1 Overview
7.5.2 Software & Services: Asia Pacific dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
8. Asia Pacific dPCR and qPCR Market – Revenue and Forecast to 2030 – by Application
8.1 Overview
8.2 Asia Pacific dPCR and qPCR Market Revenue Share, by Application, 2022 & 2030 (%)
8.3 Research Application
8.3.1 Overview
8.3.2 Research Application: Asia Pacific dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Clinical Application
8.4.1 Overview
8.4.2 Clinical Application: Asia Pacific dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
8.4.2.1 Asia Pacific dPCR and qPCR Market, by Clinical Application, 2020-2030 (US$ Million)
8.5 Forensic Application
8.5.1 Overview
8.5.2 Forensic Application: Asia Pacific dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
9. Asia Pacific dPCR and qPCR Market – Revenue and Forecast to 2030 – by End-User
9.1 Overview
9.2 Asia Pacific dPCR and qPCR Market Revenue Share, by End-User, 2022 & 2030 (%)
9.3 Hospitals and Diagnostic Centers
9.3.1 Overview
9.3.2 Hospitals and Diagnostic Centers: Asia Pacific dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Pharmaceutical and Biotechnology Companies
9.4.1 Overview
9.4.2 Pharmaceutical and Biotechnology Companies: Asia Pacific dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Research Laboratories and Academic Institutes
9.5.1 Overview
9.5.2 Research Laboratories and Academic Institutes: Asia Pacific dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
9.6 Forensic Laboratories
9.6.1 Overview
9.6.2 Forensic Laboratories: Asia Pacific dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
9.7 Clinical Research Organizations
9.7.1 Overview
9.7.2 Clinical Research Organizations: Asia Pacific dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
10. Asia Pacific dPCR and qPCR Market – Country Analysis
10.1.1 Asia Pacific dPCR and qPCR Market, by Country
10.1.1.1 China
10.1.1.1.1 China: Asia Pacific dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.1.2 China: Asia Pacific dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
10.1.1.1.3 China: Asia Pacific dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
10.1.1.1.4 China: Asia Pacific dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
10.1.1.1.4.1 China: Asia Pacific dPCR and qPCR Market, for Clinical Application by Application, 2020 – 2030 (US$ Million)
10.1.1.1.5 China: Asia Pacific dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
10.1.1.2 Japan
10.1.1.2.1 Japan: Asia Pacific dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.2.2 Japan: Asia Pacific dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
10.1.1.2.3 Japan: Asia Pacific dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
10.1.1.2.4 Japan: Asia Pacific dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
10.1.1.2.4.1 Japan: Asia Pacific dPCR and qPCR Market, for Clinical Application by Application, 2020 – 2030 (US$ Million)
10.1.1.2.5 Japan: Asia Pacific dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
10.1.1.3 India
10.1.1.3.1 India: Asia Pacific dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.3.2 India: Asia Pacific dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
10.1.1.3.3 India: Asia Pacific dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
10.1.1.3.4 India: Asia Pacific dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
10.1.1.3.4.1 India: Asia Pacific dPCR and qPCR Market, for Clinical Application by Application, 2020 – 2030 (US$ Million)
10.1.1.3.5 India: Asia Pacific dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
10.1.1.4 Australia
10.1.1.4.1 Australia: Asia Pacific dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.4.2 Australia: Asia Pacific dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
10.1.1.4.3 Australia: Asia Pacific dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
10.1.1.4.4 Australia: Asia Pacific dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
10.1.1.4.4.1 Australia: Asia Pacific dPCR and qPCR Market, for Clinical Application by Application, 2020 – 2030 (US$ Million)
10.1.1.4.5 Australia: Asia Pacific dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
10.1.1.5 South Korea
10.1.1.5.1 South Korea: Asia Pacific dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.5.2 South Korea: Asia Pacific dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
10.1.1.5.3 South Korea: Asia Pacific dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
10.1.1.5.4 South Korea: Asia Pacific dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
10.1.1.5.4.1 South Korea: Asia Pacific dPCR and qPCR Market, for Clinical Application by Application, 2020 – 2030 (US$ Million)
10.1.1.5.5 South Korea: Asia Pacific dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
10.1.1.6 Rest of Asia Pacific
10.1.1.6.1 Rest of Asia Pacific: Asia Pacific dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.6.2 Rest of Asia Pacific: Asia Pacific dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)
10.1.1.6.3 Rest of Asia Pacific: Asia Pacific dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)
10.1.1.6.4 Rest of Asia Pacific: Asia Pacific dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)
10.1.1.6.4.1 Rest of Asia Pacific: Asia Pacific dPCR and qPCR Market, for Clinical Application by Application, 2020 – 2030 (US$ Million)
10.1.1.6.5 Rest of Asia Pacific: Asia Pacific dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)
11. dPCR and qPCR Market-Industry Landscape
11.1 Overview
11.2 Growth Strategies in Asia Pacific dPCR and qPCR Market
11.3 Organic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Abbott Laboratories
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Thermo Fisher Scientific Inc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Takara Bio Inc
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Qiagen NV
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Standard BioTools Inc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Lepu Medical Technology Beijing Co Ltd
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 F. Hoffmann-La Roche Ltd
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Bio-Rad Laboratories Inc
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Agilent Technologies Inc
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Genome Diagnostics Pvt Ltd
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms

LIST OF TABLES

Table 1. Asia Pacific dPCR and qPCR Market Segmentation
Table 2. Asia Pacific dPCR and qPCR Market, by Clinical Application – Revenue and Forecast to 2030 (US$ Million)
Table 3. China: Asia Pacific dPCR and qPCR Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 4. China: Asia Pacific dPCR and qPCR Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 5. China: Asia Pacific dPCR and qPCR Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 6. China: Asia Pacific dPCR and qPCR Market, for Clinical Application by Application – Revenue and Forecast to 2030 (US$ Million)
Table 7. China: Asia Pacific dPCR and qPCR Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 8. Japan: Asia Pacific dPCR and qPCR Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 9. Japan: Asia Pacific dPCR and qPCR Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 10. Japan: Asia Pacific dPCR and qPCR Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 11. Japan: Asia Pacific dPCR and qPCR Market, for Clinical Application by Application – Revenue and Forecast to 2030 (US$ Million)
Table 12. Japan: Asia Pacific dPCR and qPCR Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 13. India: Asia Pacific dPCR and qPCR Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 14. India: Asia Pacific dPCR and qPCR Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 15. India: Asia Pacific dPCR and qPCR Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 16. India: Asia Pacific dPCR and qPCR Market, for Clinical Application by Application – Revenue and Forecast to 2030 (US$ Million)
Table 17. India: Asia Pacific dPCR and qPCR Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 18. Australia: Asia Pacific dPCR and qPCR Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 19. Australia: Asia Pacific dPCR and qPCR Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 20. Australia: Asia Pacific dPCR and qPCR Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 21. Australia: Asia Pacific dPCR and qPCR Market, for Clinical Application by Application – Revenue and Forecast to 2030 (US$ Million)
Table 22. Australia: Asia Pacific dPCR and qPCR Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 23. South Korea: Asia Pacific dPCR and qPCR Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 24. South Korea: Asia Pacific dPCR and qPCR Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 25. South Korea: Asia Pacific dPCR and qPCR Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 26. South Korea: Asia Pacific dPCR and qPCR Market, for Clinical Application by Application – Revenue and Forecast to 2030 (US$ Million)
Table 27. South Korea: Asia Pacific dPCR and qPCR Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 28. Rest of Asia Pacific: Asia Pacific dPCR and qPCR Market, by Treatment – Revenue and Forecast to 2030 (US$ Million)
Table 29. Rest of Asia Pacific: Asia Pacific dPCR and qPCR Market, by Product – Revenue and Forecast to 2030 (US$ Million)
Table 30. Rest of Asia Pacific: Asia Pacific dPCR and qPCR Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 31. Rest of Asia Pacific: Asia Pacific dPCR and qPCR Market, for Clinical Application by Application – Revenue and Forecast to 2030 (US$ Million)
Table 32. Rest of Asia Pacific: Asia Pacific dPCR and qPCR Market, by End-User – Revenue and Forecast to 2030 (US$ Million)
Table 33. Recent Organic Growth Strategies in Asia Pacific dPCR and qPCR Market
Table 34. Recent Inorganic Growth Strategies in the Asia Pacific dPCR and qPCR Market
Table 35. Glossary of Terms, Asia Pacific dPCR and qPCR Market

LIST OF FIGURES

Figure 1. Asia Pacific dPCR and qPCR Market Segmentation, By Country
Figure 2. Asia Pacific dPCR and qPCR Market – Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Asia Pacific dPCR and qPCR Market Revenue (US$ Mn), 2022 – 2030
Figure 5. Asia Pacific dPCR and qPCR Market Revenue Share, by Treatment, 2022 & 2030 (%)
Figure 6. Quantitative PCR: Asia Pacific dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. Digital PCR: Asia Pacific dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Asia Pacific dPCR and qPCR Market Revenue Share, by Product, 2022 & 2030 (%)
Figure 9. Reagents & Consumables: Asia Pacific dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Instruments: Asia Pacific dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Software & Services: Asia Pacific dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Asia Pacific dPCR and qPCR Market Revenue Share, by Application, 2022 & 2030 (%)
Figure 13. Research Application: Asia Pacific dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Clinical Application: Asia Pacific dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Forensic Application: Asia Pacific dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Asia Pacific dPCR and qPCR Market Revenue Share, by End-User, 2022 & 2030 (%)
Figure 17. Hospitals and Diagnostic Centers: Asia Pacific dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Pharmaceutical and Biotechnology Companies: Asia Pacific dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Research Laboratories and Academic Institutes: Asia Pacific dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Forensic Laboratories: Asia Pacific dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Clinical Research Organizations: Asia Pacific dPCR and qPCR Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Asia Pacific dPCR and qPCR Market, by Key Country – Revenue, 2022 (US$ Million)
Figure 23. Asia Pacific dPCR and qPCR Market, By Key Countries, 2022 and 2030 (%)
Figure 24. China: Asia Pacific dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
Figure 25. Japan: Asia Pacific dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
Figure 26. India: Asia Pacific dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
Figure 27. Australia: Asia Pacific dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
Figure 28. South Korea: Asia Pacific dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
Figure 29. Rest of Asia Pacific: Asia Pacific dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)
Figure 30. Growth Strategies in Asia Pacific dPCR and qPCR Market

The List of Companies – Asia Pacific dPCR and qPCR Market

1. Abbott Laboratories
2. Agilent Technologies Inc
3. Bio-Rad Laboratories Inc
4. F. Hoffmann-La Roche Ltd
5. Genome Diagnostics Pvt Ltd
6. Lepu Medical Technology Beijing Co Ltd
7. Qiagen NV
8. Standard BioTools Inc
9. Takara Bio Inc
10. Thermo Fisher Scientific Inc

Reviews

There are no reviews yet.

Be the first to review “Asia Pacific dPCR and qPCR Market Forecast to 2030”